Quality assessment of clinical practice guidelines for benign prostatic hyperplasia_Chinese Journal of Evidence-Based Medicine

Authors：

LI Sheng ¹ , ZENG Xiantao ¹ , LI Xiaodong ² , WU Kaijie ³ , ZI Hao ² ,  HE Dalin ³ ,  WANG Xinghuan ¹

1. Department of Urology, Zhongnan Hospital of Wuhan University, Wuhan, 430071, P.R.China;
2. Department of Urology, Huaihe Hospital of Henan University, Kaifeng, 475000, P.R.China;
3. Department of Urology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, 710061, P.R.China;

Corresponding author：

HE Dalin, Email: held@mail.xjtu.edu.cn; WANG Xinghuan, Email: wangxinghuan@whu.edu.cn

Keywords：

Benign prostatic hyperplasia; Clinical practice guideline; Quality assessment; AGREE Ⅱ

DOI：

10.7507/1672-2531.201704003

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Objectives To evaluate the methodological quality of published clinical practice guidelines for benign prostatic hyperplasia. Methods PubMed, EMbase, CNKI, WanFang Data, VIP and CBM databases, website of Yimaitong, and international authoritative guide platforms were electronically searched to collect the relevant clinical practice guidelines or consensus for benign prostate hyperplasia. The retrieval covered the time up to December 13^th, 2016. Literatures were independently screened by 2 reviewers. After data extraction, the methodological quality of included guidelines was evaluated by 4 reviewers using the AGREE Ⅱ. Each domain score was calculated and the intraclass correlation coefficient was used to evaluate the consistency among the reviewers. Results A total of 15 clinical practice guidelines were included. The mean scores for the six domains in AGREE Ⅱ were: 72%, 38%, 30%, 58%, 16%, and 40%, respectively. The intraclass correlation coefficient was larger than 0.87, which indicated the total consistency was well. Conclusions The quality of clinical practice guidelines for benign prostatic hyperplasia is not satisfactory as expected. They are heterogeneous in quality and some requires improvement. Guidelines are required to be further developed in methodology in future, especially in three domains, including participants, preciseness and applicability of the design.

Citation： LI Sheng, ZENG Xiantao, LI Xiaodong, WU Kaijie, ZI Hao, HE Dalin, WANG Xinghuan. Quality assessment of clinical practice guidelines for benign prostatic hyperplasia. Chinese Journal of Evidence-Based Medicine, 2018, 18(1): 74-80. doi: 10.7507/1672-2531.201704003 Copy

1.	Guess HA, Arrighi HM, Metter EJ, et al. Cumulative prevalence of prostatism matches the autopsy prevalence of benign prostatic hyperplasia. Prostate, 1990, 17(3): 241-246.
2.	Berry SJ, Coffey DS, Walsh PC, et al. The development of human benign prostatic hyperplasia with age. J Urol, 1984, 132(3): 474-479.
3.	李胜, 王行环. 等离子体双极电切系统在前列腺增生症手术治疗中的应用及研究进展. 中华临床医师杂志(电子版), 2011, 5(20): 6089-6093.
4.	李胜. 临床实践指南概述. 王行环, 主编. 循证临床实践指南的研发与评价(第一版). 北京: 中国协和医科大学出版社, 2016: 1-5.
5.	Novara G, Galfano A, Gardi M, et al. Critical review of guidelines for BPH diagnosis and treatment strategy. Eur Urol Suppl, 2006, 5(4): 418-429.
6.	Zeng X, Zhang Y, Kwong JS, et al. The methodological quality assessment tools for preclinical and clinical studies, systematic review and meta‐analysis, and clinical practice guideline: a systematic review. J Evid Based Med, 2015, 8(1): 2-10.
7.	Gratzke C, Bachmann A, Descazeaud A, et al. EAU Guidelines on the assessment of non-neurogenic male lower urinary tract symptoms including benign prostatic obstruction. Eur Urol, 2015, 67(6): 1099-1109.
8.	张祥华, 王行环, 王刚, 等. 良性前列腺增生临床诊治指南. 中华外科杂志, 2007, 45(24): 1704-1707.
9.	Homma Y, Gotoh M, Yokoyama O, et al. Outline of JUA clinical guidelines for benign prostatic hyperplasia. Int J Urol, 2011, 18(11): 741-756.
10.	朱刚, 王建业, 王东文, 等. 老年人良性前列腺增生/下尿路症状药物治疗共识. 中华老年医学杂志, 2011, 30(11): 889-893.
11.	Cavalcanti AGLC, Errico G, Araujo JFC, et al. Hiperplasia Prostática Benigna. Brazil: Brazilian Urological Association, 2006.
12.	Tammela T, Hellström P, Juusela H, et al. Eturauhasen hyvänlaatuinen liikakasvu. Duodecim, 2006, 122: 107-108.
13.	Berges R, Dreikorn K, Höfner K, et al. Diagnostik und differenzialdiagnostik des benignen prostatasyndroms (BPS). Der Urologe, 2009, 48(11): 1356-1364.
14.	Guidelines International Network. Therapie des benignen Prostatasyndroms (BPS). Scotland: GIN, 2014.
15.	The management of lower urinary tract symptoms in men. National Institute for Health and Clinical Excellence (serial online). London: NICE, 2010 (cited 2016 Jun 5). Available at: https://www.nice.org.uk/Guidance/CG97.
16.	Cockett A, Aso Y, Denis L, et al. World Health Organization Consensus Committee recommendations concerning the diagnosis of BPH. Prog Urol, 1991, 1(6): 957-972.
17.	Spatafora S, Casarico A, Fandella A, et al. Evidence-based guidelines for the treatment of lower urinary tract symptoms related to uncomplicated benign prostatic hyperplasia in Italy: updated summary from AURO. Ther Adv Urol, 2012, 4(6): 279-301.
18.	Lei CCM, Abdullah K, Mah P, et al. Consensus on management of benign prostatic hyperplasia. Available at: www. acadmed.org.my/view_file.cfm?fileid=221.
19.	Nickel JC, Mendez-Probst CE, Whelan TF, et al. 2010 Update: Guidelines for the management of benign prostatic hyperplasia. Can Urol Assoc J, 2010, 4(5): 310-316.
20.	McVary KT, Roehrborn CG, Avins AL, et al. Update on AUA guideline on the management of benign prostatic hyperplasia. J Urol, 2011, 185(5): 1793-1803.
21.	Bereczky Z, Bolus M, Chetty P, et al. Management of benign prostatic hyperplasia-South African Urological Association Guideline. S Afr Med J, 2006, 96(12 Pt 3): 1275-1279.
22.	王小钦, 王吉耀, 主编. 循证临床实践指南的制定与实施. 北京: 人民卫生出版社, 2016.
23.	曾宪涛, 吴凡, 邬兰, 等. 中国口腔医学领域临床实践指南的循证评价. 中国循证医学杂志, 2015, 15(3): 264-269.
24.	邢丹, 王斌, 侯云飞, 等. 中国骨科临床实践指南的质量评价. 中国循证医学杂志, 2017, 17(3): 347-356.
25.	Jiang M, Liao LY, Liu XQ, et al. Quality assessment of clinical practice guidelines for respiratory diseases in China: a systematic appraisal. Chest, 2015, 148(3): 759-766.
26.	Chen Y, Hu S, Wu L, et al. Clinical practice guidelines for hypertension in China: a systematic review of the methodological quality. BMJ Open, 2015, 5(7): e008099.
27.	陈昊, 李广林, 徐文韬, 等. 国内循证针灸临床实践指南的质量评价. 中国循证医学杂志, 2014, 14(6): 772-775.
28.	Jin Y, Wang Y, Zhang Y, et al. Nursing practice guidelines in China do need reform: a critical appraisal using the AGREEⅡ instrument. Worldviews Evid Based Nurs, 2016, 13(2): 124-138.

1. Guess HA, Arrighi HM, Metter EJ, et al. Cumulative prevalence of prostatism matches the autopsy prevalence of benign prostatic hyperplasia. Prostate, 1990, 17(3): 241-246.
2. Berry SJ, Coffey DS, Walsh PC, et al. The development of human benign prostatic hyperplasia with age. J Urol, 1984, 132(3): 474-479.
3. 李胜, 王行环. 等离子体双极电切系统在前列腺增生症手术治疗中的应用及研究进展. 中华临床医师杂志(电子版), 2011, 5(20): 6089-6093.
4. 李胜. 临床实践指南概述. 王行环, 主编. 循证临床实践指南的研发与评价(第一版). 北京: 中国协和医科大学出版社, 2016: 1-5.
5. Novara G, Galfano A, Gardi M, et al. Critical review of guidelines for BPH diagnosis and treatment strategy. Eur Urol Suppl, 2006, 5(4): 418-429.
6. Zeng X, Zhang Y, Kwong JS, et al. The methodological quality assessment tools for preclinical and clinical studies, systematic review and meta‐analysis, and clinical practice guideline: a systematic review. J Evid Based Med, 2015, 8(1): 2-10.
7. Gratzke C, Bachmann A, Descazeaud A, et al. EAU Guidelines on the assessment of non-neurogenic male lower urinary tract symptoms including benign prostatic obstruction. Eur Urol, 2015, 67(6): 1099-1109.
8. 张祥华, 王行环, 王刚, 等. 良性前列腺增生临床诊治指南. 中华外科杂志, 2007, 45(24): 1704-1707.
9. Homma Y, Gotoh M, Yokoyama O, et al. Outline of JUA clinical guidelines for benign prostatic hyperplasia. Int J Urol, 2011, 18(11): 741-756.
10. 朱刚, 王建业, 王东文, 等. 老年人良性前列腺增生/下尿路症状药物治疗共识. 中华老年医学杂志, 2011, 30(11): 889-893.
11. Cavalcanti AGLC, Errico G, Araujo JFC, et al. Hiperplasia Prostática Benigna. Brazil: Brazilian Urological Association, 2006.
12. Tammela T, Hellström P, Juusela H, et al. Eturauhasen hyvänlaatuinen liikakasvu. Duodecim, 2006, 122: 107-108.
13. Berges R, Dreikorn K, Höfner K, et al. Diagnostik und differenzialdiagnostik des benignen prostatasyndroms (BPS). Der Urologe, 2009, 48(11): 1356-1364.
14. Guidelines International Network. Therapie des benignen Prostatasyndroms (BPS). Scotland: GIN, 2014.
15. The management of lower urinary tract symptoms in men. National Institute for Health and Clinical Excellence (serial online). London: NICE, 2010 (cited 2016 Jun 5). Available at: https://www.nice.org.uk/Guidance/CG97.
16. Cockett A, Aso Y, Denis L, et al. World Health Organization Consensus Committee recommendations concerning the diagnosis of BPH. Prog Urol, 1991, 1(6): 957-972.
17. Spatafora S, Casarico A, Fandella A, et al. Evidence-based guidelines for the treatment of lower urinary tract symptoms related to uncomplicated benign prostatic hyperplasia in Italy: updated summary from AURO. Ther Adv Urol, 2012, 4(6): 279-301.
18. Lei CCM, Abdullah K, Mah P, et al. Consensus on management of benign prostatic hyperplasia. Available at: www. acadmed.org.my/view_file.cfm?fileid=221.
19. Nickel JC, Mendez-Probst CE, Whelan TF, et al. 2010 Update: Guidelines for the management of benign prostatic hyperplasia. Can Urol Assoc J, 2010, 4(5): 310-316.
20. McVary KT, Roehrborn CG, Avins AL, et al. Update on AUA guideline on the management of benign prostatic hyperplasia. J Urol, 2011, 185(5): 1793-1803.
21. Bereczky Z, Bolus M, Chetty P, et al. Management of benign prostatic hyperplasia-South African Urological Association Guideline. S Afr Med J, 2006, 96(12 Pt 3): 1275-1279.
22. 王小钦, 王吉耀, 主编. 循证临床实践指南的制定与实施. 北京: 人民卫生出版社, 2016.
23. 曾宪涛, 吴凡, 邬兰, 等. 中国口腔医学领域临床实践指南的循证评价. 中国循证医学杂志, 2015, 15(3): 264-269.
24. 邢丹, 王斌, 侯云飞, 等. 中国骨科临床实践指南的质量评价. 中国循证医学杂志, 2017, 17(3): 347-356.
25. Jiang M, Liao LY, Liu XQ, et al. Quality assessment of clinical practice guidelines for respiratory diseases in China: a systematic appraisal. Chest, 2015, 148(3): 759-766.
26. Chen Y, Hu S, Wu L, et al. Clinical practice guidelines for hypertension in China: a systematic review of the methodological quality. BMJ Open, 2015, 5(7): e008099.
27. 陈昊, 李广林, 徐文韬, 等. 国内循证针灸临床实践指南的质量评价. 中国循证医学杂志, 2014, 14(6): 772-775.
28. Jin Y, Wang Y, Zhang Y, et al. Nursing practice guidelines in China do need reform: a critical appraisal using the AGREEⅡ instrument. Worldviews Evid Based Nurs, 2016, 13(2): 124-138.

Chinese Journal of Evidence-Based Medicine

Quality assessment of clinical practice guidelines for benign prostatic hyperplasia

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content